Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC

(AGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Form 8.3 - Allergan Plc

share with twitter share with LinkedIn share with facebook
share via e-mail
03/03/2020 | 10:16am EDT
TIDM0Y7T TIDM0QCV 
 
 
   FORM 8.3 
 
   IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, 
TAKEOVER RULES, 2013 
 
   DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 
1% OR MORE 
 
   1. KEY INFORMATION 
 
 
 
 
Name of person dealing (Note 1)                State Street Global Advisors & 
                                               Affiliates 
---------------------------------------------  ------------------------------- 
Company dealt in                               Allergan plc 
---------------------------------------------  ------------------------------- 
Class of relevant security to which            US$0.0001 ordinary shares 
 the dealings being disclosed relate (Note 2) 
---------------------------------------------  ------------------------------- 
Date of dealing                                02(nd) March 2020 
---------------------------------------------  ------------------------------- 
 
 
 
   2. INTERESTS AND SHORT POSITIONS 
 
   (a) Interests and short positions (following dealing) in the class of 
relevant security dealt in (Note 3) 
 
 
 
 
                                               Long             Short 
-------------------------------------  --------------------  ----------- 
                                         Number      (%)     Number  (%) 
-------------------------------------  ----------  --------  ------  --- 
(1) Relevant securities                13,379,010  4.06659% 
-------------------------------------  ----------  --------  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------  ----------  --------  ------  --- 
(3) Options and agreements to 
 purchase/sell                                N/A 
-------------------------------------  ----------  --------  ------  --- 
Total                                  13,379,010  4.06659% 
-------------------------------------  ----------  --------  ------  --- 
 
 
   (b) Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 3) 
 
 
 
 
Class of relevant security:                     Long         Short 
-------------------------------------------  -----------  ----------- 
                                             Number  (%)  Number  (%) 
-------------------------------------------  ------  ---  ------  --- 
(1) Relevant securities                       N/A 
-------------------------------------------  ------  ---  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------------  ------  ---  ------  --- 
(3) Options and agreements to purchase/sell   N/A 
-------------------------------------------  ------  ---  ------  --- 
Total                                         N/A 
-------------------------------------------  ------  ---  ------  --- 
 
 
   3. DEALINGS (Note 4) 
 
   (a) Purchases and sales 
 
 
 
 
Purchase/sale   Number of relevant securities  Price per unit (Note 5) 
--------------  -----------------------------  ----------------------- 
   Purchase                               300                   193.84 
--------------  -----------------------------  ----------------------- 
   Purchase                               300                   192.92 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,400                   193.84 
--------------  -----------------------------  ----------------------- 
   Purchase                               100                   193.84 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,000                   193.84 
--------------  -----------------------------  ----------------------- 
   Purchase                                64                   192.16 
--------------  -----------------------------  ----------------------- 
   Purchase                            55,948                   193.84 
--------------  -----------------------------  ----------------------- 
   Purchase                             2,652                   193.84 
--------------  -----------------------------  ----------------------- 
   Purchase                             5,304                   193.84 
--------------  -----------------------------  ----------------------- 
   Purchase                               400                   189.13 
--------------  -----------------------------  ----------------------- 
     Sale                               1,000                   188.66 
--------------  -----------------------------  ----------------------- 
     Sale                                 300                   192.13 
--------------  -----------------------------  ----------------------- 
     Sale                               1,100                   193.84 
--------------  -----------------------------  ----------------------- 
     Sale                               1,000                   193.84 
--------------  -----------------------------  ----------------------- 
     Sale                                 100                   191.91 
--------------  -----------------------------  ----------------------- 
     Sale                                 400                   189.10 
--------------  -----------------------------  ----------------------- 
     Sale                               2,700                   191.01 
--------------  -----------------------------  ----------------------- 
     Sale                                 100                   193.84 
--------------  -----------------------------  ----------------------- 
     Sale                                 800                   193.05 
--------------  -----------------------------  ----------------------- 
     Sale                              21,670                   193.84 
--------------  -----------------------------  ----------------------- 
     Sale                                 552                   193.84 
--------------  -----------------------------  ----------------------- 
     Sale                                  44                   193.84 
--------------  -----------------------------  ----------------------- 
     Sale                                 437                   193.84 
--------------  -----------------------------  ----------------------- 
     Sale                                 120                   193.84 
--------------  -----------------------------  ----------------------- 
     Sale                                 100                   192.98 
--------------  -----------------------------  ----------------------- 
     Sale                                 126                   193.84 
--------------  -----------------------------  ----------------------- 
     Sale                               7,375                   193.84 
--------------  -----------------------------  ----------------------- 
 Transfer In                 406                         N/A 
--------------  -----------------------------  ----------------------- 
 
 
 
 
 
   (b) Derivatives transactions (other than options transactions) 
 
 
 
 
Product name,  Nature of transaction  Number of relevant securities  Price per unit 
 e.g. CFD       (Note 6)               (Note 7)                       (Note 5) 
-------------  ---------------------  -----------------------------  -------------- 
N/A 
-------------  ---------------------  -----------------------------  -------------- 
 
 
 
   (c) Options transactions in respect of existing relevant securities 
 
   (i) Writing, selling, purchasing or varying 
 
 
 
 
Product name,      Writing, selling,  Number of             Exercise  Type, e.g.      Expiry  Option money 
 e.g. call option   purchasing         securities to which   price     American,       date    paid/received 
                    varying etc.       the option relates              European etc.           per unit (Note 5) 
                                       (Note 7) 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
N/A 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
 
 
   (ii) Exercising 
 
 
 
 
Product name,      Number of securities  Exercise price per 
 e.g. call option                           unit (Note 5) 
-----------------  --------------------  ------------------ 
N/A 
-----------------  --------------------  ------------------ 
 
 
   (d) Other dealings (including transactions in respect of new securities) 
(Note 4) 
 
 
 
 
Nature of transaction  Details       Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                     NO 
-------------------------------------------------------  ----------------- 
Date of disclosure                                       03(rd) March 2020 
-------------------------------------------------------  ----------------- 
Contact name                                               Lionel Colaco 
-------------------------------------------------------  ----------------- 
Telephone number                                              020 33956098 
-------------------------------------------------------  ----------------- 

(MORE TO FOLLOW) Dow Jones Newswires

03-03-20 1015ET

Stocks mentioned in the article
ChangeLast1st jan.
ALLERGAN PLC 0.02% 193.02 Delayed Quote.0.97%
BYD COMPANY LIMITED -1.17% 42.4 End-of-day quote.9.14%
NEXT 7.17% 4911.59 Delayed Quote.-34.70%
This article is part of a news chaine.
Article 1 / 2
<< Preceding Next >>
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ALLERGAN PLC
05/14Allergan, Ideal Implant Issued Warning Letters From FDA Related to Breast Imp..
DJ
05/11ABBVIE : Completes Transformative Acquisition of Allergan
AQ
05/08ALLERGAN PLC : Completion of Acquisition or Disposition of Assets, Notice of Del..
AQ
05/08ALLERGAN : AbbVie Inc. Completes Acquisition of Allergan plc
PR
05/08Form 8.3 -Allergan Plc
DJ
05/07Form 8.3 - Allergan Plc
DJ
05/07ALLERGAN : Foundation Doubles its COVID-19 Response Donations to $4.0 Million
PR
05/07ALLERGAN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
05/06DexCom and Domino's Pizza to Join S&P 500; Salesforce.com to Join S&P 100
DJ
05/06DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
More news
Chart ALLERGAN PLC
Duration : Period :
Allergan plc Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers
NameTitle
Robert A. Michael President & Director
Scott Reents Director
Ryan Quigley Director
Andres Rodrigo Director
Basil Blakeney Director
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN PLC0.97%63 659
JOHNSON & JOHNSON-1.03%380 356
ROCHE HOLDING AG11.15%306 144
PFIZER, INC.-4.29%208 306
MERCK & CO., INC.-16.03%192 766
NOVARTIS AG-9.56%188 520